Richard Klausner has been named senior vice president and chief medical officer at Illumina.
Klausner joins Illumina from the Column Group, a venture capital firm. He previously served as executive director for global health at the Bill and Melinda Gates Foundation and as director of the US National Cancer Institute from 1995 to 2001.
Klausner holds an MD from Duke Medical School.
Dietrich Stephan has been named chair of the department of human genetics at the University of Pittsburgh Graduate School of Public Health and will also serve as the associate director of the Institute for Personalized Medicine, a collaborative initiative between the University of Pittsburgh Schools of the Health Sciences and UPMC.
Stephan was most recently founder, president, and CEO of Silicon Valley Biosystems. He also co-founded personal genetics firm Navigenics. Prior to that, Stephan held a number of roles at the Translational Genomics Research Institute, including director of neurogenomics. He was also head of the NIH Neuroscience Microarray Consortium for seven years.